Letters Overtreatment

Fashionable to criticise the drug industry?

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7089 (Published 24 October 2012) Cite this as: BMJ 2012;345:e7089
  1. Stephen Whitehead, chief executive
  1. 1Association of the British Pharmaceutical Industry, London SW1E 6QT, UK
  1. press{at}abpi.org.uk

McCartney makes several disparate claims about the drug industry.1 She states that the financial relations between charities and the industry are “unclear” and implies that this unduly influences the daily activities of the third sector. In reality, the Association of the British Pharmaceutical Industry’s code of practice requires that companies publicly declare their financial transactions with charities and the nature of …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe